>
Industry
Health Care
Topic
Financial Results
People
Find news about people
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Financial Results in Health Care

... MARLBOROUGH - RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company developing the next generation of immuno-oncology ...
... SOUTH SAN FRANCISCO - Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), a company developing and commercializing proprietary therapeutics for the treatment ...
... based on the Import Drug Approval registration pathway. CASI is working with Spectrum Pharmaceuticals, and its vendors, from whom EVOMELA is in-licensed to address the ...
... LEXINGTON - Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company devoted to development of next-generation medicines to improve the ...
... WESTMINSTER - ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to ...
... VANCOUVER - DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) ('DelMar' or the 'Company'), a biopharmaceutical company focused on the ...
... TORONTO - Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for ...
... SOUTH SAN FRANCISCO - Mateon Therapeutics, Inc. (OTCQB: MATN), a biopharmaceutical company developing investigational drugs for the treatment ...
... anxiety. We were also pleased to have in-licensed a late-stage asset from AstraZeneca, which potentially offers patients suffering from MSA with a much-needed novel treatment ...
... FREMONT - Zosano Pharma Corporation (NASDAQ: ZSAN) ('Zosano' or the 'Company'), a clinical-stage biopharmaceutical company, today announced ...
Subscribe now for full coverage on Financial Results in Health Care
Start My Free Trial